While adopting new technology is obviously a big part of healthcare innovation teams’ work, there are plenty of worthwhile initiatives that don’t involve advanced technologies, pointed out Dan Shoenthal, chief innovation officer at MD Anderson Cancer Center.
The Senate voted 72-18 Thursday to confirm Hahn, a radiation oncologist and chief medical executive at The University of Texas MD Anderson Cancer Center.
A new independent study from Phyx Primary Care’s Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices.
HHS announced that it had nominated Dr. Stephen Hahn as the next FDA commissioner. Acting Commissioner Ned Sharpless will return to the National Cancer Institute, while HHS official Brett Giroir will temporarily step in pending Hahn's confirmation.
Dr. Stephen Hahn, a radiation oncologist and MD Anderson's chief medical executive, has reportedly been in the running since September to succeed former FDA Commissioner Scott Gottlieb and current acting commissioner Ned Sharpless.
BioCentury reported that the the nomination of radiation oncologist Dr. Stephen Hahn, who had been under consideration, would follow an FBI background check. Acting Commissioner Ned Sharpless and Brett Giroir, an assistant HHS secretary, had also reportedly been in the running.
Trump is reportedly considering Dr. Stephen Hahn to head the FDA. Others reportedly under consideration include acting Commissioner Ned Sharpless and HHS assistant secretary Brett Giroir.
Your varicose or spider veins may indicate an underlying problem, so finding the right vein specialist is crucial. Discover the best vein clinics in Orlando.
The two organizations are placing particular emphasis on lung and gastrointestinal cancers, as well as drug targets like KRAS mutations.
The violations date back to three separate breach reports in 2012 and 2013, which involve the stealing of an unencrypted laptop and the loss of two unencrypted USB thumb drives.
We're not six months into 2017 yet. But already, a number of healthcare leaders have turned in their resignation letters due to significant problems at their organizations.
In its first year at SXSW, a series of conversations around the topic of cancer, Connect to End Cancer, spurred some interesting discussion around telemedicine, advice for startups and the role of 5g technology to improve patient-physician encounters.
Break down the silos. Take control of your provider data.
Indianapolis-based SonarMed continues to move forward with perfecting and providing its non-invasive, adjunctive device that provides real-time monitoring of endotracheal tube position and function, originally developed at Purdue University by SonarMed founders Dr. Jeffrey Mansfield, Dr. Eduardo Juan, and Dr. George Wodicka.